Defense strategists and trial lawyers

The Atlanta office of Hawkins Parnell & Young was recognized in the 2020 edition of “Best Law Firms” by U.S. News – Best Lawyers.

David is recognized nationally as a trailblazer in employee benefits and executive compensation, including employee stock ownership plans (ESOPs), equity incentive plans, and non-qualified deferred compensation.

Claire Weglarz secured an outright dismissal two weeks into trial in a personal injury mesothelioma case pending in Marion County, Indiana. The client, a company that provides mechanical contractor services at industrial and commercial facilities across the nation, was the only remaining defendant at trial. 

Ollie Harton secured a defense verdict after a two-week trial in North Carolina federal court in a personal injury mesothelioma case.

Ryan Marden and Nina Moreno secured a defense verdict for a major automobile manufacturer in a lemon law case.

Hawkins Parnell & Young is ranked #39 among U.S. law firms in The American Lawyer’s 2019 Diversity Scorecard.

Hawkins Parnell & Young is pleased to announce Laura Kugler has joined the Dallas office. Her arrival brings the firm’s number of Texas-attorneys to 20.

Hawkins Parnell & Young was named the “Mid-Size Firm of the Year” by the Atlanta Bar Association.

In a food poisoning case, Hawkins Parnell & Young secured a dismissal in trial followed by a victory on the appeal. The Supreme Court of New Jersey denied the petition to appeal the dismissal.

As a trial lawyer for more than 35 years, John brings extensive experience representing government entities and corporations from the manufacturing, construction, and transportation sectors.

Hawkins Parnell & Young is pleased to announce the election of Edward P. Abbot and Catherine E. Goldhaber as equity partners.

Ranelle Meroney secured a defense victory for H-E-B after a three day trial in Waco, Texas. The case involved allegations of employee negligence resulting in catastrophic injuries to a customer.

A recent boost in cosmetics litigation, especially related to talcum powder, has reinvigorated a debate about the breadth of the U.S. FDA’s authority over cosmetic products and their ingredients.